🇺🇸 FDA
Pipeline program

Tasimelteon Oral Capsule, Tasimelteon Liquid Suspension

VP-VEC-162-3601

Phase 3 small_molecule active

Quick answer

Tasimelteon Oral Capsule, Tasimelteon Liquid Suspension for Autism Spectrum Disorder is a Phase 3 program (small_molecule) at Vanda Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Vanda Pharmaceuticals
Indication
Autism Spectrum Disorder
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials